株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心筋バイオマーカーの世界市場:業界動向、市場シェア、市場規模、成長性、市場機会、および将来予測

Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

発行 IMARC Services Private Limited 商品コード 788429
出版日 ページ情報 英文 130 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.62円で換算しております。
Back to Top
心筋バイオマーカーの世界市場:業界動向、市場シェア、市場規模、成長性、市場機会、および将来予測 Cardiac Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
出版日: 2019年02月11日 ページ情報: 英文 130 Pages
概要

当レポートでは、心筋バイオマーカーの世界市場を取り上げ、業界動向や市場実績、価格動向、また市場競争状況など広範な調査に基づいて、SWOT分析、Porterのファイブフォース分析、バリューチェーン分析等の重要な市場分析結果を提供しています。さらに市場をタイプ別、検査場所別、対象疾患別、および地域別に分類し、詳細な分析と将来予測を行っています。

第1章 前書き

第2章 調査範囲および調査手法

  • 調査目的
  • 利害関係者
  • データソース
  • 市場見積法
  • 予測手法

第3章 エグゼクティブ・サマリー

第4章 序論

  • 市場概要
  • 主要業界動向

第5章 心筋バイオマーカー世界市場

  • 市場概要
  • 市場実績
  • タイプ別市場分析
  • 検査場所別市場分析
  • 対象疾患別市場分析
  • 地域別市場分析
  • 市場予測

第6章 タイプ別市場分析

  • トロポニン (TおよびI)
    • 市場動向
    • 市場予測
  • 心筋クレアチンキナーゼ (CK-MB)
  • ミオグロビン
  • 脳性ナトリウム利尿ペプチド(BNP)またはNT-proBNP (脳性ナトリウム利尿ペプチド前駆体N端フラグメント)
  • 虚血変性アルブミン (IMA)
  • その他

第7章 検査場所別市場分析

  • 臨床検査室検査
    • 市場動向
    • 市場予測
  • 臨床現場即時検査 (POCT)

第8章 対象疾患別市場分析

  • 心筋梗塞
    • 市場動向
    • 市場予測
  • 鬱血性心不全
  • 急性冠動脈症候群
  • アテローム性動脈硬化症
  • その他

第9章 地域別市場分析

  • 北米
    • 市場動向
    • 市場予測
  • アジア太平洋
  • 欧州
  • 中東およびアフリカ
  • ラテンアメリカ

第10章 世界の心筋バイオマーカー産業:SWOT分析

第11章 世界の心筋バイオマーカー産業:バリューチェーン分析

第12章 世界の心筋バイオマーカー産業:Porterのファイブフォース分析

第13章 世界の心筋バイオマーカー産業:価格分析

第14章 市場競争状況

  • 市場構造
  • 主要企業
  • 主要企業プロファイル
    • Abbott Laboratories
    • Alere Inc.
    • Beckman Coulter
    • Becton, Dickinson And Co.
    • Biomerieux
    • Bio-Rad Laboratories
    • Randox Laboratories
    • Roche Diagnostics Corporation
    • Siemens Healthcare
    • Thermo Fisher Scientific
図表

List of Figures

  • Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2011-2018
  • Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2018
  • Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2018
  • Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2018
  • Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2018
  • Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2019-2024
  • Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
  • Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
  • Figure 10: Global: Cardiac Biomarkers Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2019-2024
  • Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2011 & 2018
  • Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2019-2024

List of Tables

  • Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2018 and 2024
  • Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2019-2024
  • Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2019-2024
  • Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2019-2024
  • Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2019-2024
  • Table 6: Global: Cardiac Biomarkers Market Structure
  • Table 7: Global: Cardiac Biomarkers Market: Key Players
目次
Product Code: SR1018H7_Report

The global cardiac biomarkers market was worth US$ 6.9 Billion in 2018. Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients. Looking forward, the market value is projected to reach US$ 11.6 Billion by 2024, expanding at a CAGR of around 9% during 2019-2024.

Global Cardiac Biomarkers Market Drivers:

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Market Summary:

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global share.

The competitive landscape of the market has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key Questions Answered in This Report:

  • How has the global cardiac biomarkers market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global cardiac biomarkers industry?
  • What is the breakup of the global cardiac biomarkers market on the basis of type?
  • What is the breakup of the global cardiac biomarkers market on the basis of location of testing?
  • What is the breakup of the global cardiac biomarkers market on the basis of application?
  • What are the various stages in the value chain of the global cardiac biomarkers market?
  • What are the key driving factors and challenges in the global cardiac biomarkers market?
  • What is the structure of the global cardiac biomarkers market and who are the key players?
  • What is the degree of competition in the global cardiac biomarkers market?

Table of Contents

1. Preface

2. Scope and Methodology

  • 2.1. Objectives of the Study
  • 2.2. Stakeholders
  • 2.3. Data Sources
    • 2.3.1. Primary Sources
    • 2.3.2. Secondary Sources
  • 2.4. Market Estimation
    • 2.4.1. Bottom-Up Approach
    • 2.4.2. Top-Down Approach
  • 2.5. Forecasting Methodology

3. Executive Summary

4. Introduction

  • 4.1. Overview
  • 4.2. Key Industry Trends

5. Global Cardiac Biomarkers Market

  • 5.1. Market Overview
  • 5.2. Market Performance
  • 5.3. Market Breakup by Type
  • 5.4. Market Breakup by Location of Testing
  • 5.5. Market Breakup by Application
  • 5.6. Market Breakup by Region
  • 5.7. Market Forecast

6. Market Breakup by Type

  • 6.1. Troponins (T and I)
    • 6.1.1. Market Trends
    • 6.1.2. Market Forecast
  • 6.2. Myocardial Muscle Creatine Kinase (CK-MB)
    • 6.2.1. Market Trends
    • 6.2.2. Market Forecast
  • 6.3. Myoglobin
    • 6.3.1. Market Trends
    • 6.3.2. Market Forecast
  • 6.4. Brain Natriuretic Peptide (BNPs) or NT-proBNP
    • 6.4.1. Market Trends
    • 6.4.2. Market Forecast
  • 6.5. Ischemia Modified Albumin (IMA)
    • 6.5.1. Market Trends
    • 6.5.2. Market Forecast
  • 6.6. Others
    • 6.6.1. Market Trends
    • 6.6.2. Market Forecast

7. Market Breakup by Location of Testing

  • 7.1. Laboratory Testing
    • 7.1.1. Market Trends
    • 7.1.2. Market Forecast
  • 7.2. Point of Care Testing
    • 7.2.1. Market Trends
    • 7.2.2. Market Forecast

8. Market Breakup by Application

  • 8.1. Myocardial Infarction
    • 8.1.1. Market Trends
    • 8.1.2. Market Forecast
  • 8.2. Congestive Heart Failure
    • 8.2.1. Market Trends
    • 8.2.2. Market Forecast
  • 8.3. Acute Coronary Syndrome
    • 8.3.1. Market Trends
    • 8.3.2. Market Forecast
  • 8.4. Atherosclerosis
    • 8.4.1. Market Trends
    • 8.4.2. Market Forecast
  • 8.5. Others
    • 8.5.1. Market Trends
    • 8.5.2. Market Forecast

9. Market Breakup by Region

  • 9.1. North America
    • 9.1.1. Market Trends
    • 9.1.2. Market Forecast
  • 9.2. Asia Pacific
    • 9.2.1. Market Trends
    • 9.2.2. Market Forecast
  • 9.3. Europe
    • 9.3.1. Market Trends
    • 9.3.2. Market Forecast
  • 9.4. Middle East and Africa
    • 9.4.1. Market Trends
    • 9.4.2. Market Forecast
  • 9.5. Latin America
    • 9.5.1. Market Trends
    • 9.5.2. Market Forecast

10. Global Cardiac Biomarkers Industry: SWOT Analysis

  • 10.1. Overview
  • 10.2. Strengths
  • 10.3. Weaknesses
  • 10.4. Opportunities
  • 10.5. Threats

11. Global Cardiac Biomarkers Industry: Value Chain Analysis

12. Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

  • 12.1. Overview
  • 12.2. Bargaining Power of Buyers
  • 12.3. Bargaining Power of Suppliers
  • 12.4. Degree of Competition
  • 12.5. Threat of New Entrants
  • 12.6. Threat of Substitutes

13. Global Cardiac Biomarkers Industry: Price Analysis

14. Competitive Landscape

  • 14.1. Market Structure
  • 14.2. Key Players
  • 14.3. Profiles of Key Players
    • 14.3.1. Abbott Laboratories
    • 14.3.2. Alere Inc.
    • 14.3.3. Beckman Coulter
    • 14.3.4. Becton, Dickinson And Co.
    • 14.3.5. Biomerieux
    • 14.3.6. Bio-Rad Laboratories
    • 14.3.7. Randox Laboratories
    • 14.3.8. Roche Diagnostics Corporation
    • 14.3.9. Siemens Healthcare
    • 14.3.10 Thermo Fisher Scientific
Back to Top